Da Pang
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Breast Cancer Treatment Studies 37
- Cancer-related molecular mechanisms research 19
- Cancer Genomics and Diagnostics 9
- Oncology 34
- Cancer Immunotherapy and Biomarkers 8
- HER2/EGFR in Cancer Research 8
- Co-authors
- Shouping Xu (32 shared papers)Shiyao Sui (9 shared papers)Xianyu Zhang (32 shared papers)Peiyuan Wang (5 shared papers)Shanshan Sun (16 shared papers)Guoqiang Zhang (12 shared papers)Zilong You (13 shared papers)Yongdong Jiang (17 shared papers)
- Journals
- PLoS ONE (12 papers)Oncotarget (10 papers)Breast Cancer Research and Treatment (9 papers)Frontiers in Oncology (7 papers)Tumor Biology (6 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Da Pang
163 papers receiving 5.9k citations
Da Pang's Hit Papers
Peers
Comparison fields: 5 of 109
- Cancer Research 2.2k
- Oncology 1k
- Molecular Biology 1.4k
- Pulmonary and Respiratory Medicine 511
- Pathology and Forensic Medicine 263
Countries citing papers authored by Da Pang
This map shows the geographic impact of Da Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da Pang more than expected).
Fields of papers citing papers by Da Pang
This network shows the impact of papers produced by Da Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da Pang. The network helps show where Da Pang may publish in the future.
Co-authors
The 25 scholars most cited alongside Da Pang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 166 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Hit paper breakdown → | 2022 | 329 |
| 2 | 2019 | 200 | |
| 3 | 2021 | 197 | |
| 4 | 2017 | 180 | |
| 5 | 2019 | 153 | |
| 6 | 2019 | 129 | |
| 7 | Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer. | 2015 | 128 |
| 8 | 2013 | 123 | |
| 9 | 2017 | 119 | |
| 10 | 2011 | 110 | |
| 11 | 2013 | 110 | |
| 12 | 2019 | 105 | |
| 13 | 2017 | 99 | |
| 14 | 2021 | 99 | |
| 15 | 2017 | 98 | |
| 16 | 2012 | 96 | |
| 17 | 2017 | 96 | |
| 18 | 2012 | 92 | |
| 19 | 2016 | 90 | |
| 20 | 2015 | 83 |
About Da Pang
Da Pang is a scholar working on Cancer Research, Oncology, Molecular Biology, Genetics and Immunology, having authored 166 papers that have together received 6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (37 papers), Epigenetics and DNA Methylation (23 papers), Cancer-related molecular mechanisms research (19 papers), Genetic Associations and Epidemiology (16 papers), Cancer Genomics and Diagnostics (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), HER2/EGFR in Cancer Research (8 papers) and BRCA gene mutations in cancer (8 papers). The work is most often cited by research in Cancer Research (2.2k citations), Oncology (1k citations), Molecular Biology (1.4k citations), Pulmonary and Respiratory Medicine (511 citations) and Pathology and Forensic Medicine (263 citations). Da Pang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Shouping Xu, Shiyao Sui, Xianyu Zhang, Peiyuan Wang, Shanshan Sun, Guoqiang Zhang, Zilong You, Yongdong Jiang, Yashuang Zhao and Shipeng Ning. Their work appears in journals such as PLoS ONE, Oncotarget, Breast Cancer Research and Treatment, Frontiers in Oncology and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.